|
Name |
Accession |
Description |
Interval |
E-value |
| MdaB |
COG2249 |
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ... |
1-195 |
2.38e-63 |
|
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];
Pssm-ID: 441850 [Multi-domain] Cd Length: 190 Bit Score: 194.67 E-value: 2.38e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 1 MKQVAVEELSKQGCTVTVSDLYTMNFEPRATRNDvtgalsnpevfkygieayeAYKKKALTSDILEEQRKVQEADLVIFQ 80
Cdd:COG2249 18 LAEAAAEGLEAAGHEVTVHDLYAEGFDPVLSAAD-------------------FYRDGPLPIDVAAEQELLLWADHLVFQ 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 81 FPLYWFSVPAILKGWMDRVLCQGFAFDVPGFYDSGFLKDKLALLSFTTGGTAEMYTKAGVNGDFRYFlwpLQHGTLHFCG 160
Cdd:COG2249 79 FPLWWYSMPALLKGWIDRVLTPGFAYGYGGGYPGGLLKGKKALLVVTTGGPEEAYSRLGYGGPIEEL---LFRGTLGYCG 155
|
170 180 190
....*....|....*....|....*....|....*
gi 564391223 161 FKVLAPQISFGPEVSSEEQRKVMLASWVQRLKSIW 195
Cdd:COG2249 156 MKVLPPFVLYGVDRSSDEERAAWLERVRELLAALA 190
|
|
| Flavodoxin_2 |
pfam02525 |
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ... |
3-191 |
4.24e-50 |
|
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.
Pssm-ID: 426816 [Multi-domain] Cd Length: 193 Bit Score: 160.96 E-value: 4.24e-50
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 3 QVAVEELSKQGCTVTVSDLYTMnFEPRATRNDVTgALSNPEVFKygieayeaykkkaltsDILEEQRKVQEADLVIFQFP 82
Cdd:pfam02525 21 DALVEALKAAGHEVTVRDLYAL-FLPVLDAEDLA-DLTYPQGAA----------------DVESEQEELLAADVIVFQFP 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 83 LYWFSVPAILKGWMDRVLCQGFAFDVP-GFYDSGFLKDKLALLSFTTGGTAEMYTKAGVNG-DFRYFLWPLqHGTLHFCG 160
Cdd:pfam02525 83 LYWFSVPALLKGWIDRVLRAGFAFKYEeGGPGGGGLLGKKVLVIVTTGGPEYAYGKGGYNGfSLDELLPYL-RGILGFCG 161
|
170 180 190
....*....|....*....|....*....|..
gi 564391223 161 FKVLAPQISFG-PEVSSEEQRKVMLASWVQRL 191
Cdd:pfam02525 162 ITDLPPFAVEGtAGPEDEAALAEALERYEERL 193
|
|
| PRK04930 |
PRK04930 |
glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional |
63-146 |
1.85e-17 |
|
glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional
Pssm-ID: 179895 [Multi-domain] Cd Length: 184 Bit Score: 76.58 E-value: 1.85e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 63 DILEEQRKVQEADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDVPGfydsGFLKDKLALLSFTTGGTAEMYTKAGVNg 142
Cdd:PRK04930 51 DIPHEQALLREHDVIVFQHPLYTYSCPALLKEWLDRVLSRGFASGPGG----NALAGKYWRSVITTGEPESAYRYDGYN- 125
|
....
gi 564391223 143 dfRY 146
Cdd:PRK04930 126 --RY 127
|
|
|
|
Name |
Accession |
Description |
Interval |
E-value |
| MdaB |
COG2249 |
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ... |
1-195 |
2.38e-63 |
|
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];
Pssm-ID: 441850 [Multi-domain] Cd Length: 190 Bit Score: 194.67 E-value: 2.38e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 1 MKQVAVEELSKQGCTVTVSDLYTMNFEPRATRNDvtgalsnpevfkygieayeAYKKKALTSDILEEQRKVQEADLVIFQ 80
Cdd:COG2249 18 LAEAAAEGLEAAGHEVTVHDLYAEGFDPVLSAAD-------------------FYRDGPLPIDVAAEQELLLWADHLVFQ 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 81 FPLYWFSVPAILKGWMDRVLCQGFAFDVPGFYDSGFLKDKLALLSFTTGGTAEMYTKAGVNGDFRYFlwpLQHGTLHFCG 160
Cdd:COG2249 79 FPLWWYSMPALLKGWIDRVLTPGFAYGYGGGYPGGLLKGKKALLVVTTGGPEEAYSRLGYGGPIEEL---LFRGTLGYCG 155
|
170 180 190
....*....|....*....|....*....|....*
gi 564391223 161 FKVLAPQISFGPEVSSEEQRKVMLASWVQRLKSIW 195
Cdd:COG2249 156 MKVLPPFVLYGVDRSSDEERAAWLERVRELLAALA 190
|
|
| Flavodoxin_2 |
pfam02525 |
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ... |
3-191 |
4.24e-50 |
|
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.
Pssm-ID: 426816 [Multi-domain] Cd Length: 193 Bit Score: 160.96 E-value: 4.24e-50
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 3 QVAVEELSKQGCTVTVSDLYTMnFEPRATRNDVTgALSNPEVFKygieayeaykkkaltsDILEEQRKVQEADLVIFQFP 82
Cdd:pfam02525 21 DALVEALKAAGHEVTVRDLYAL-FLPVLDAEDLA-DLTYPQGAA----------------DVESEQEELLAADVIVFQFP 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 83 LYWFSVPAILKGWMDRVLCQGFAFDVP-GFYDSGFLKDKLALLSFTTGGTAEMYTKAGVNG-DFRYFLWPLqHGTLHFCG 160
Cdd:pfam02525 83 LYWFSVPALLKGWIDRVLRAGFAFKYEeGGPGGGGLLGKKVLVIVTTGGPEYAYGKGGYNGfSLDELLPYL-RGILGFCG 161
|
170 180 190
....*....|....*....|....*....|..
gi 564391223 161 FKVLAPQISFG-PEVSSEEQRKVMLASWVQRL 191
Cdd:pfam02525 162 ITDLPPFAVEGtAGPEDEAALAEALERYEERL 193
|
|
| PRK04930 |
PRK04930 |
glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional |
63-146 |
1.85e-17 |
|
glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional
Pssm-ID: 179895 [Multi-domain] Cd Length: 184 Bit Score: 76.58 E-value: 1.85e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 63 DILEEQRKVQEADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDVPGfydsGFLKDKLALLSFTTGGTAEMYTKAGVNg 142
Cdd:PRK04930 51 DIPHEQALLREHDVIVFQHPLYTYSCPALLKEWLDRVLSRGFASGPGG----NALAGKYWRSVITTGEPESAYRYDGYN- 125
|
....
gi 564391223 143 dfRY 146
Cdd:PRK04930 126 --RY 127
|
|
| PRK00871 |
PRK00871 |
glutathione-regulated potassium-efflux system oxidoreductase KefF; |
63-197 |
1.24e-15 |
|
glutathione-regulated potassium-efflux system oxidoreductase KefF;
Pssm-ID: 234852 Cd Length: 176 Bit Score: 71.35 E-value: 1.24e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 63 DILEEQRKVQEADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDVPGFYdsgfLKDKLALLSFTTGGtAEMYTKAGVNG 142
Cdd:PRK00871 45 DIAAEQEALSRADLIVWQHPMQWYSIPPLLKLWIDKVLSHGWAYGHGGTA----LHGKHLLWAVTTGG-GESHFEIGAHP 119
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*
gi 564391223 143 DFRYFLWPLQhGTLHFCGFKVLAPQISFGPEVSSEEQRKVMLASWVQRLKSiWKE 197
Cdd:PRK00871 120 GFDVLSQPLQ-ATALYCGLNWLPPFAMHCTFICDDETLEGQARHYKQRLLE-WQE 172
|
|
| PRK09739 |
PRK09739 |
NAD(P)H oxidoreductase; |
6-139 |
2.50e-14 |
|
NAD(P)H oxidoreductase;
Pssm-ID: 236620 [Multi-domain] Cd Length: 199 Bit Score: 68.58 E-value: 2.50e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 6 VEELSKQGCTVTVSDLYTMNFEPRATRNDvTGALSNPEvfkygieayeaykkKALTSDILEEQRKVQEADLVIFQFPLYW 85
Cdd:PRK09739 27 HQRAQERGHQVEELDLYRSGFDPVLTPED-EPDWKNPD--------------KRYSPEVHQLYSELLEHDALVFVFPLWW 91
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....
gi 564391223 86 FSVPAILKGWMDRVLCQGFAFDvpgfyDSGFLKDKLALLSFTTGGTAEMYTKAG 139
Cdd:PRK09739 92 YSFPAMLKGYIDRVWNNGLAYG-----DGHKLPFNKVRWVALVGGSKESFVKRG 140
|
|
| AzoR |
COG1182 |
FMN-dependent NADH-azoreductase [Energy production and conversion]; |
6-181 |
3.91e-09 |
|
FMN-dependent NADH-azoreductase [Energy production and conversion];
Pssm-ID: 440795 [Multi-domain] Cd Length: 205 Bit Score: 54.37 E-value: 3.91e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 6 VEELSKQ--GCTVTVSDLYTMNFePRATrNDVTGALSNPEvfkygiEAYEAYKKKALT-SDILEEQrkVQEADLVIFQFP 82
Cdd:COG1182 26 VAALRAAhpDDEVTYRDLAAEPL-PHLD-GAWLAAFFTPA------EGRTPEQQAALAlSDELIDE--LLAADVIVIGAP 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 83 LYWFSVPAILKGWMDRVLCQG--FAFDVPGFydSGFLKDKLALLSFTTGGTaemYTKAGVNG-DF--RYflwpLQHgTLH 157
Cdd:COG1182 96 MYNFGIPSQLKAWIDHIARAGrtFRYTENGP--VGLLTGKKAVVITARGGV---YSGGPAAGmDFqtPY----LRT-VLG 165
|
170 180
....*....|....*....|....*...
gi 564391223 158 FCGFK----VLAPQISFGPEVSSEEQRK 181
Cdd:COG1182 166 FIGITdvefVRAEGTAAGPEAAEAALAA 193
|
|
| WrbA |
COG0655 |
Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and ... |
1-131 |
2.49e-07 |
|
Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and conversion];
Pssm-ID: 440420 [Multi-domain] Cd Length: 181 Bit Score: 48.77 E-value: 2.49e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 1 MKQVAVEELSKQGCTVTVSDLYTMNFEPratrndvtgalsnpevfkygIEAYEAYKKKALTSDILEEQRKVQEADLVIFQ 80
Cdd:COG0655 18 LAEAVAEGAEEAGAEVELIRLADLDIKP--------------------CIGCGGTGKCVIKDDMNAIYEKLLEADGIIFG 77
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|.
gi 564391223 81 FPLYWFSVPAILKGWMDRvlCQGFAFDVpgfydsGFLKDKLALLsFTTGGT 131
Cdd:COG0655 78 SPTYFGNMSAQLKAFIDR--LYALWAKG------KLLKGKVGAV-FTTGGH 119
|
|
| PRK00170 |
PRK00170 |
azoreductase; Reviewed |
59-130 |
7.91e-07 |
|
azoreductase; Reviewed
Pssm-ID: 234675 [Multi-domain] Cd Length: 201 Bit Score: 47.58 E-value: 7.91e-07
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 564391223 59 ALTSDILEEqrkVQEADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDvpgfYDS----GFLKDKLALLSFTTGG 130
Cdd:PRK00170 75 ALSDELLEE---FLAADKIVIAAPMYNFSIPTQLKAYIDLIARAGKTFR----YTEngpvGLVTGKKALLITSRGG 143
|
|
| FMN_red |
pfam03358 |
NADPH-dependent FMN reductase; |
69-132 |
3.37e-04 |
|
NADPH-dependent FMN reductase;
Pssm-ID: 427259 [Multi-domain] Cd Length: 152 Bit Score: 39.53 E-value: 3.37e-04
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 564391223 69 RKVQEADLVIFQFPLYWFSVPAILKGWMDRvlcqgfafdVPGFYDSGFLKDKLALLsFTTGGTA 132
Cdd:pfam03358 65 EKIAAADAIIIVTPEYNGSVSGLLKNAIDW---------LSRLRGGKELRGKPVAI-VSTGGGR 118
|
|
| PRK13556 |
PRK13556 |
FMN-dependent NADH-azoreductase; |
15-125 |
3.85e-04 |
|
FMN-dependent NADH-azoreductase;
Pssm-ID: 184140 [Multi-domain] Cd Length: 208 Bit Score: 40.13 E-value: 3.85e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 564391223 15 TVTVSDLYTMNFePRATRNDVTGalsnpeVFK--YGIEAYEAYKKKALTSDILEEQrkVQEADLVIFQFPLYWFSVPAIL 92
Cdd:PRK13556 38 TVVELDLYKEEL-PYVGVDMING------TFKagKGFELTEEEAKAVAVADKYLNQ--FLEADKVVFAFPLWNFTIPAVL 108
|
90 100 110
....*....|....*....|....*....|....
gi 564391223 93 KGWMDRVLCQGFAFDVPGFYDSGFLKD-KLALLS 125
Cdd:PRK13556 109 HTYIDYLNRAGKTFKYTPEGPVGLIGDkKVALLN 142
|
|
|